A study highlights the effectiveness of Talimogene laherparepvec (TVEC) for basal cell carcinoma. The virus-based therapy reduced tumor size in 50% of cases, enabled complete tumor regression in a third and activated immune defenses.
This is an automated archive made by the Lemmit Bot.
The original was posted on /r/tech by /u/chrisdh79 on 2025-01-29 00:45:44+00:00.